HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.

Autor: Zecher BF; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Leibniz Institute of Virology, Hamburg, Germany., Ellinghaus D; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Schloer S; Leibniz Institute of Virology, Hamburg, Germany., Niehrs A; Leibniz Institute of Virology, Hamburg, Germany., Padoan B; Leibniz Institute of Virology, Hamburg, Germany., Baumdick ME; Leibniz Institute of Virology, Hamburg, Germany., Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Martin MP; Basic Science Program, Frederick National Laboratory for Cancer Research and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Glow D; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schröder-Schwarz J; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Niersch J; Leibniz Institute of Virology, Hamburg, Germany., Brias S; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Leibniz Institute of Virology, Hamburg, Germany., Müller LM; Leibniz Institute of Virology, Hamburg, Germany., Habermann R; Leibniz Institute of Virology, Hamburg, Germany., Kretschmer P; Leibniz Institute of Virology, Hamburg, Germany., Früh T; Leibniz Institute of Virology, Hamburg, Germany., Dänekas J; Leibniz Institute of Virology, Hamburg, Germany., Wehmeyer MH; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Poch T; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Sebode M; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Ellinghaus E; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Degenhardt F; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Körner C; Leibniz Institute of Virology, Hamburg, Germany., Hoelzemer A; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Leibniz Institute of Virology, Hamburg, Germany., Fehse B; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Oldhafer KJ; Department of General & Abdominal Surgery, Asklepios Hospital Barmbek, Hamburg, Germany., Schumacher U; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Franke A; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Bunders MJ; Leibniz Institute of Virology, Hamburg, Germany.; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schramm C; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Martin Zeitz Center for Rare Diseases and Hamburg Centre for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Altfeld M; Leibniz Institute of Virology, Hamburg, Germany marcus.altfeld@leibniz-liv.de.; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publikováno v: Gut [Gut] 2024 Jan 05; Vol. 73 (2), pp. 325-337. Date of Electronic Publication: 2024 Jan 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Local Passive Heat for the Treatment of Hypertension in Autonomic Failure.

Autor: Okamoto LE; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Celedonio JE; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Smith EC; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Gamboa A; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Shibao CA; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Diedrich A; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN.; Department of Biomedical Engineering Vanderbilt University Medical Center Nashville TN., Paranjape SY; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Black BK; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Muldowney JAS 3rd; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Division of Cardiology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Peltier AC; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Neurology Vanderbilt University Medical Center Nashville TN., Habermann R; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Division of Geriatrics Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN., Crandall CG; Institute for Exercise and Environmental Medicine Texas Health Presbyterian Hospital and UT Southwestern Medical Center Dallas TX., Biaggioni I; Vanderbilt Autonomic Dysfunction Center Vanderbilt University Medical Center Nashville TN.; Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville TN.; Department of Medicine Vanderbilt University Medical Center Nashville TN.; Department of Pharmacology Vanderbilt University Medical Center Nashville TN.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2021 Apr 06; Vol. 10 (7), pp. e018979. Date of Electronic Publication: 2021 Mar 19.

Prevalence of Spasticity in Nursing Home Residents.

Autor: Gill CE; Department of Neurology, Rush University Medical Center, Chicago, IL., Hacker ML; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN; Department of Medicine, Vanderbilt University Medical Center, Center for Quality Aging, Nashville, TN., Meystedt J; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN., Turchan M; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN., Schnelle JF; Department of Medicine, Vanderbilt University Medical Center, Center for Quality Aging, Nashville, TN., Simmons SF; Department of Medicine, Vanderbilt University Medical Center, Center for Quality Aging, Nashville, TN; Geriatric Research Education & Clinical Center, Tennessee Valley VA Healthcare System, Nashville, TN., Habermann R; Geriatric Research Education & Clinical Center, Tennessee Valley VA Healthcare System, Nashville, TN., Phibbs FT; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN., Charles D; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN. Electronic address: David.Charles@vumc.org.

Publikováno v: Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2020 Aug; Vol. 21 (8), pp. 1157-1160. Date of Electronic Publication: 2020 Feb 19.

A Structured Literature Review of Nurses' Perceptions Concerning the Use of Chemical Restraints Amongst People with Dementia and the Perceived Barriers to Non-Pharmacological Approaches.

Autor: Jacobs, Jeremy¹ (AUTHOR) jeremy.jacobs@health.wa.gov.au, Wei, Li¹ (AUTHOR), Slatyer, Susan¹ (AUTHOR)

Publikováno v: SAGE Open. Jul-Sep2024, Vol. 14 Issue 3, p1-14. 14p.